PRP effect on ovary

Not Applicable

• Conditions: Primary ovarian failure.; Primary ovarian failure; E28.3

• Registration Number: IRCT20180528039878N5
• Lead Sponsor: Mehr Medical Institute

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 6 March 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Female
• Target Recruitment: 20

Inclusion Criteria

Age less than 40 years
The number of antral follicles is less than 5
Anti-Müllerian hormone level less than 0.3 nano-grams/milliliter

Exclusion Criteria

Women with autoimmune disorders
Anemia
Thrombophilic disorders
Current cancer or medical history of cancer
Severe male infertility
Endometriosis

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The total number of oocytes retrieved. Timepoint: The day of ovarian puncture before platelet rich plasma injection, The day of ovarian puncture after platelet rich plasma injection. Method of measurement: According to the count.;The total number of metaphase II oocytes. Timepoint: The day of ovarian puncture before platelet rich plasma injection, The day of ovarian puncture after platelet rich plasma injection. Method of measurement: According to the count.

Secondary Outcome Measures

Name	Time	Method
Basal level of Anti-Müllerian Hormone. Timepoint: Serum level on the third day of the menstrual cycle before platelet-rich plasma injection, Serum level on the third day of the menstrual cycle after platelet-rich plasma injection. Method of measurement: Using the test kit.;Number of embryos. Timepoint: In the cycle before platelet-rich plasma injection, In the cycle after platelet-rich plasma injection. Method of measurement: According to the count.